Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 3 1

Status

Withdrawn 1Unknown 1Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 5OTHER_GOV 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Breast Neoplasms 9481Neoplasms 6589Prostatic Neoplasms 4399Colorectal Neoplasms 3978Lung Neoplasms 3644Carcinoma, Non-Small-Cell Lung 3585Pancreatic Neoplasms 2479Carcinoma, Hepatocellular 2413Leukemia, Myeloid, Acute 2265Multiple Myeloma 2121Stomach Neoplasms 2109Neoplasm Metastasis 1911Head and Neck Neoplasms 1870Ovarian Neoplasms 1773Precursor Cell Lymphoblastic Leukemia-Lymphoma 1734Lymphoma 1730Brain Neoplasms 1702Rectal Neoplasms 1676Melanoma 1656Colonic Neoplasms 1629Leukemia 1500Uterine Cervical Neoplasms 1499Recurrence 1486Esophageal Neoplasms 1312Glioblastoma 1308Lymphoma, Non-Hodgkin 1205Leukemia, Lymphocytic, Chronic, B-Cell 1120Squamous Cell Carcinoma of Head and Neck 1109Urinary Bladder Neoplasms 1078Lymphoma, Follicular 1067

Interventions

Radiosurgery 3toripalimab 1Sorafenib 1Radiotherapy 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Radiotherapy × Clear all
NCT04709380 2025-02-26

Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 3 Terminated
36 enrolled
Gastrointestinal

Radiotherapy

NCT06566222 2024-08-22

Chemoradiotherapy After Surgery Versus Preoperative Chemoradiotherapy for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors

Changhai Hospital

Not yet recruiting
2,000 enrolled

Radiotherapy

NCT05349552 2023-12-27

Safety and Efficacy of SBRT in the Treatment of Thoracic Malignant Tumors at Different Sites

Peking University Third Hospital

Recruiting
120 enrolled
Thoracic

Radiotherapy

NCT02441270 2021-07-13

Evaluation of the Immunological Effects of a Combined Treatment With Radiation and Cyclophosphamide in Metastasized Breast Cancer Patients

University Hospital, Ghent

Phase EARLY_PHASE1 Withdrawn

Radiotherapy

NCT03963713 2019-07-19

SCIRSM

Peking University Third Hospital

Phase NA Unknown
100 enrolled

Radiotherapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡